First National Bank of Omaha reduced its holdings in shares of PerkinElmer, Inc. (NYSE:PKI) by 71.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 37,200 shares of the medical research company’s stock after selling 92,146 shares during the quarter. First National Bank of Omaha’s holdings in PerkinElmer were worth $1,592,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Kohmann Bosshard Financial Services LLC bought a new position in shares of PerkinElmer during the third quarter worth about $107,000. Tower Research Capital LLC TRC grew its position in PerkinElmer by 69.1% in the 3rd quarter. Tower Research Capital LLC TRC now owns 1,972 shares of the medical research company’s stock valued at $191,000 after buying an additional 806 shares in the last quarter. Ibex Investors LLC bought a new position in PerkinElmer in the 3rd quarter valued at about $206,000. Conning Inc. bought a new position in PerkinElmer in the 3rd quarter valued at about $212,000. Finally, Sapphire Star Partners LP bought a new position in PerkinElmer in the 3rd quarter valued at about $221,000. Institutional investors own 95.25% of the company’s stock.
Shares of PKI stock opened at $93.77 on Thursday. PerkinElmer, Inc. has a 12 month low of $70.83 and a 12 month high of $98.33. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.16 and a current ratio of 1.60. The company has a market cap of $10.41 billion, a price-to-earnings ratio of 25.98, a P/E/G ratio of 1.84 and a beta of 1.24.
The company also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Friday, April 19th will be given a $0.07 dividend. The ex-dividend date of this dividend is Wednesday, April 17th. This represents a $0.28 annualized dividend and a yield of 0.30%. PerkinElmer’s dividend payout ratio (DPR) is currently 7.76%.
A number of brokerages have weighed in on PKI. Zacks Investment Research raised shares of PerkinElmer from a “hold” rating to a “buy” rating and set a $86.00 price target for the company in a report on Thursday, January 3rd. Needham & Company LLC initiated coverage on shares of PerkinElmer in a research note on Wednesday, January 2nd. They set a “hold” rating and a $79.00 price objective for the company. Janney Montgomery Scott lowered shares of PerkinElmer from a “buy” rating to a “neutral” rating in a research note on Friday, November 2nd. UBS Group set a $92.00 price objective on shares of PerkinElmer and gave the company a “hold” rating in a research note on Saturday, February 2nd. Finally, Cowen reaffirmed a “hold” rating and set a $85.00 price objective on shares of PerkinElmer in a research note on Sunday, January 6th. Ten research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $80.99.
In other PerkinElmer news, Director Nicholas A. Lopardo sold 2,000 shares of PerkinElmer stock in a transaction on Friday, November 30th. The stock was sold at an average price of $87.08, for a total transaction of $174,160.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Alexis P. Michas sold 5,000 shares of PerkinElmer stock in a transaction on Monday, December 3rd. The shares were sold at an average price of $90.95, for a total value of $454,750.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 8,600 shares of company stock valued at $777,182. 2.10% of the stock is owned by company insiders.
PerkinElmer, Inc provides products, services, and solutions to the diagnostics, research, environmental, industrial, food, and laboratory services markets worldwide. The company operates in two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers analytical technologies, solutions, and services for the environmental market that enable its customers to understand the characterization and health of various aspects, including air, water, and soil.
See Also: What is the yield curve?
Receive News & Ratings for PerkinElmer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer and related companies with MarketBeat.com's FREE daily email newsletter.